North Star Investment Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1K Hold
75
﹤0.01% 950
2025
Q4
$15.5K Hold
75
﹤0.01% 879
2025
Q3
$13.4K Hold
75
﹤0.01% 864
2025
Q2
$12.1K Hold
75
﹤0.01% 860
2025
Q1
$12.8K Hold
75
﹤0.01% 817
2024
Q4
$12.5K Hold
75
﹤0.01% 827
2024
Q3
$12.9K Hold
75
﹤0.01% 793
2024
Q2
$11.5K Sell
75
-74
-50% -$11.1K ﹤0.01% 792
2024
Q1
$22.9K Buy
149
+74
+99% +$11.3K ﹤0.01% 718
2023
Q4
$11.9K Hold
75
﹤0.01% 797
2023
Q3
$11K Hold
75
﹤0.01% 813
2023
Q2
$11.5K Hold
75
﹤0.01% 829
2023
Q1
$11.6K Hold
75
﹤0.01% 846
2022
Q4
$11.6K Hold
75
﹤0.01% 827
2022
Q3
$10K Hold
75
﹤0.01% 802
2022
Q2
$10K Hold
75
﹤0.01% 822
2022
Q1
$11K Hold
75
﹤0.01% 855
2021
Q4
$12K Hold
75
﹤0.01% 866
2021
Q3
$12K Hold
75
﹤0.01% 829
2021
Q2
$13K Hold
75
﹤0.01% 806
2021
Q1
$12K Hold
75
﹤0.01% 763
2020
Q4
$13K Hold
75
﹤0.01% 739
2020
Q3
$12K Hold
75
﹤0.01% 722
2020
Q2
$13K Hold
75
﹤0.01% 683
2020
Q1
$10K Hold
75
﹤0.01% 720
2019
Q4
$11K Hold
75
﹤0.01% 798
2019
Q3
$9K Buy
+75
New +$9.98K ﹤0.01% 830

Other funds holding FBT

North Star Investment Management's FBT Position: Q1 2026 in Review

North Star Investment Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 75 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #950.

North Star Investment Management first reported a position in FBT in Q3 2019 and has held it in 27 quarters since. The position peaked at $22.9K in Q1 2024. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • North Star Investment Management held 75 shares of First Trust NYSE Arca Biotechnology Index Fund worth $15.1K as of Q1 2026.
  • North Star Investment Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #950 holding.
  • North Star Investment Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2019 and has held it in 27 quarters since.
  • North Star Investment Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $22.9K in Q1 2024.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.